Table 1 Demographic and biologic data
From: Pharmacodynamics of cisatracurium in the intensive care unit: an observational study
ICU patients | Surgical patients | P | |
|---|---|---|---|
N = 17 | N = 17 | ||
Age (years) | 60 (28 to 83) | 56 (26 to 86) | 0.89 |
Sex (M/F) | 13/4 | 11/6 | 0.88 |
Weight (kg) | 75 (55 to 128) | 71 (51 to 83) | 0.076 |
Height (cm) | 160 (144 to 175) | 169 (158 to 186) | 0.099 |
BMI | 29 (27 to 39) | 26 (22 to 37) | 0.083 |
Urea (mmol.L-1) | 10.9 (3.60 to 31) | 6 (3.4 to 23.6) | 0.02a |
Creatinine (μmol.L-1) | 84 (41 to 211) | 88.50 (63.6 to 407) | 0.67 |
Creatinine clearance | 86.7 (29.8 to 159.4) | 76.6 (13 to 113.4) | 0.42 |
(ml.min-1.1.73 m2-1 ) | |||
Prothrombin rate | 66 (20 to 89) | 87 (64 to100) | 0.001a |
SGOT ( IU.L-1) | 40 (14 to 274) | 34 (14 to 183) | 0.33 |
SGPT ( IU.L-1) | 44 (15 to 425) | 57 (13 to 293) | 0.52 |
Protein (g.L-1) | 55 (35 to 65) | 71 (60 to 80) | < 0.001a |